Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/9/13 17:13 | 8/8/13 | ENDP | Health | Drug | Pharmaceutical Preparations | Kimmel Roger H | NY | D | P | 200 | 36.50 | 33 | 5 | 12 | 52 | D | 9 | 24 | 23 | 0 | -1 | -3 | -3 | -5 | 0 | 2 | 20 | 53 | 89 | 72 | |
3/6/13 19:02 | 3/5/13 | ENDP | Health | Drug | Pharmaceutical Preparations | Nash David | PA | D | P | 21 | 30.80 | 33 | 1 | 7 | 10 | D | -13 | -17 | -4 | 8 | 12 | 8 | 11 | 0 | 0 | -2 | 8 | 17 | 34 | 146 | |
11/14/12 17:29 | 11/12/12 | ENDP | Health | Drug | Pharmaceutical Preparations | Holveck David | PA | DO | P,CEO | P | 199 | 26.84 | 33 | 7 | 31 | 31 | D | -25 | -17 | -21 | -18 | -18 | -12 | -9 | 2 | 4 | 3 | 1 | 9 | 26 | 144 |
6/19/12 17:00 | 6/15/12 | ENDP | Health | Drug | Pharmaceutical Preparations | Levin Alan G | PA | O | EVP,CFO | P | 95 | 29.68 | 33 | 3 | New | 3 | D | 36 | -21 | -13 | -17 | -11 | -12 | 0 | 3 | 2 | -1 | 2 | 11 | -13 | 24 |
6/14/12 17:02 | 6/12/12 | ENDP | Health | Drug | Pharmaceutical Preparations | Holveck David | PA | DO | P,CEO | P | 250 | 29.23 | 33 | 9 | 55 | 24 | D | 33 | -26 | -19 | -19 | -15 | -12 | -5 | -2 | 4 | 6 | 4 | 15 | -8 | 35 |
8/26/11 16:47 | 8/25/11 | ENDP | Health | Drug | Pharmaceutical Preparations | Holveck David | PA | DO | P,CEO | P | 248 | 30.30 | 33 | 8 | 112 | 16 | D | 34 | 7 | -12 | -26 | -25 | -11 | -7 | 2 | 3 | 4 | -10 | 6 | 24 | 5 |
12/9/10 17:16 | 12/7/10 | ENDP | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D | P | 36 | 36.38 | 33 | 1 | New | 1 | I | 61 | 83 | 67 | 27 | -2 | 2 | 0 | -1 | 1 | 1 | -3 | -1 | 8 | -6 | |
5/18/09 08:56 | 5/13/09 | ENDP | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D | P | 49 | 16.31 | 27 | 3 | 77 | 7 | D | -51 | -36 | -17 | -30 | -12 | -12 | -2 | -2 | 2 | 1 | 5 | 34 | 42 | 35 | |
3/10/09 17:28 | 3/10/09 | ENDP | Health | Drug | Pharmaceutical Preparations | Holveck David | PA | DO | P,CEO | P | 485 | 16.74 | 32 | 29 | New | 29 | -1 | 3 | 3 | -1 | 34 | 41 | |||||||||
8/4/08 21:38 | 8/4/08 | ENDP | Health | Drug | Pharmaceutical Preparations | Scodari Joseph C | PA | D | P | 49 | 23.02 | 33 | 2 | 102 | 4 | D | -26 | -29 | -11 | -2 | -1 | -3 | -6 | -3 | 0 | 2 | -2 | -21 | -2 | -8 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |